PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology, Montefiore Health Systems, Albert Einstein College of Medicine, Bronx, NY.\', \'Division of Hematology/Oncology, Children\'s Hospital of Michigan/Central Michigan University, Detroit, MI.\', \'Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.\', \'Division of Pediatric Hematology, Montefiore Health Systems, Albert Einstein College of Medicine, Bronx, NY.\', \'Division of Pediatric Hematology/Oncology, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY.\', \'Department of Emergency Medicine, Boston University School of Medicine, Boston, MA.\', \'Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.\', \'Center for Pharmacoepidemiology and Pharmacoeconomic Research, College of Pharmacy, and.\', \'Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL; and.\', \'The Pulmonary Center, Boston University School of Medicine, Boston, MA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1182/bloodadvances.2020003456
?:hasPublicationType
?:journal
  • Blood advances
is ?:pmid of
?:pmid
?:pmid
  • 33570644
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all